Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 865.95, up by 12.60 points or 1.48% from its previous closing of Rs. 853.35 on the BSE.

The scrip opened at Rs. 853.45 and has touched a high and low of Rs. 875.00 and Rs. 852.65 respectively. So far 69160 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 875.00 on 26-Aug-2014 and a 52 week low of Rs. 476.45 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs. 875.00 and Rs. 803.35 respectively. The current market cap of the company is Rs. 179456.00 crore.

The promoters holding in the company stood at 63.65% while Institutions and Non-Institutions held 28.05% and 8.29% respectively.

Sun Pharmaceutical Industries’ arm - Caraco Pharmaceutical Laboratories, has initiated a recall of multiple lots of Cephalexin capsules from the US market. The recall of the 340,553 units of 500 mg and 113,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to USFDA in June under ‘Class-II’ classification.

Cephalexin is an antibiotic that belongs to the family of medications known as cephalosporins. It is used to treat certain types of bacterial infections.

Class II recall is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.